Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial

Sequential Therapy for 10 Days Versus Triple Therapy for 14 Days in the First-line Treatment of Helicobacter pylori Infection— A Multicenter, Open-label, Randomized Trial

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2013.09.043 ◽

2014 ◽

Vol 12 (1) ◽

pp. 161-162 ◽

Cited By ~ 2

Author(s):

Jyh-Ming Liou ◽

Chieh-Chang Chen ◽

Chi-Yang Chang ◽

Jeng-Yi Wu ◽

You-Jen Fang ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Sequential Therapy ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.12892 ◽

2015 ◽

Vol 30 (7) ◽

pp. 1134-1139 ◽

Cited By ~ 20

Author(s):

Tiing Leong Ang ◽

Kwong Ming Fock ◽

Mingjun Song ◽

Daphne Ang ◽

Andrew Boon Eu Kwek ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Sequential Therapy ◽

Line Treatment ◽

Concomitant Therapy ◽

First Line ◽

Su1283 – Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy in First-Line Treatment of Helicobacter Pylori Infection: A Nationwide Randomized Trial in Korea

Gastroenterology ◽

10.1016/s0016-5085(19)38208-3 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-529

Author(s):

Jae G. Kim ◽

Jae J. Kim ◽

Yong Chan Lee ◽

Il Ju Choi ◽

Soon Man Yoon ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Line Treatment ◽

First Line ◽

A Multicenter, Open-Label, Randomized Trial of Vonoprazan Versus PPI Based 7-Day Triple Therapy for the First-Line Treatment of Helicobacter Pylori Infection

Gastroenterology ◽

10.1016/s0016-5085(17)31131-9 ◽

2017 ◽

Vol 152 (5) ◽

pp. S250

Author(s):

Soichiro Sue ◽

Hirohumi Kuwashima ◽

Isao Arima ◽

Marina Ogushi ◽

Satoshi Nakao ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Su1190 Berberine-,Allicin-or Clarithromycin-Based Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection: an Open-Label, Randomized Trial

Gastroenterology ◽

10.1016/s0016-5085(14)61437-2 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-398 ◽

Cited By ~ 4

Author(s):

Xiaomei Zhang ◽

Yunsheng Yang ◽

Sun Gang ◽

Chao Yang ◽

Mingliang Lu ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea

Gut and Liver ◽

10.5009/gnl19136 ◽

2019 ◽

Vol 13 (5) ◽

pp. 531-540 ◽

Cited By ~ 10

Author(s):

Beom Jin Kim ◽

Hyuk Lee ◽

Yong Chan Lee ◽

Seong Woo Jeon ◽

Gwang Ha Kim ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Line Treatment ◽

First Line ◽

10-Days Concomitant Therapy, 10-Day Bismuth Quadruple Therapy, and 14-Day Triple Therapy in the First Line Treatment of Helicobacter Pylori Infection - A Multicenter Randomized Trial

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2016.09.028 ◽

2017 ◽

Vol 15 (1) ◽

pp. 155-156

Author(s):

Po-Yueh Chen ◽

Jyh-Ming Liou ◽

Yu-Jen Fang ◽

Chieh-Chang Chen ◽

Chi-Yang Chang ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Triple Therapy ◽

Line Treatment ◽

Concomitant Therapy ◽

First Line ◽

Quadruple Therapy ◽

Multicenter Randomized Trial ◽

Su1153 Standard Triple Therapy for Helicobacter pylori Is Still the Best First Line Treatment in Brazil, Compared With Sequential Therapy: A Randomized, Prospective, Double-Blind, Placebo-Controlled Study

Gastroenterology ◽

10.1016/s0016-5085(14)61401-3 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-390 ◽

Cited By ~ 1

Author(s):

Jaime N. Eisig ◽

Tomás Navarro-Rodriguez ◽

Ana Cristina Teixeira ◽

Fernando M. Silva ◽

Rejane Mattar ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Sequential Therapy ◽

Controlled Study ◽

Line Treatment ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Standard Triple Therapy ◽

Efficacy and tolerability of a triple therapy containing a potassium-competitive acid blocker as first-line treatment for Helicobacter pylori infection

10.26226/morressier.57c53841d462b80296c9c9d4 ◽

2016 ◽

Author(s):

Sho Suzuki

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Line Treatment ◽

First Line ◽

Faculty Opinions recommendation of Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964930.793468200 ◽

2012 ◽

Author(s):

Yoshio Yamaoka ◽

Seiji Shiota

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Randomised Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽